ACTIVE

D5-PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

26,5 k €

+140.2% YoY

Gross margin

299,3 k €

+43.9% YoY

Equity

115,5 k €

-46.0% YoY

Workforce

3,0 ETP

-6.3% YoY

What does D5-PHARMA do?

D5-PHARMA is a Private limited company incorporated in 2003. Its registered office is in Ganshoren. It employs on average 3,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0479.659.456

Incorporation

27/02/2003

Legal form

Private limited company

Registered office

Avenue de Jette 295
1083 Ganshoren · BruxellesSee on map

Contributed capital

6 200,00 €

Latest accounts

31/12/2025

Average workforce

3,0 ETP

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	299,3 k €	+43.9%	207,9 k €	+2.1%	203,6 k €	-16.7%	244,3 k €	+4.9%	233 k €	-8.5%	254,7 k €	+16.9%	217,8 k €	+16.4%	187,1 k €	-12.1%	213 k €	-16.2%	254,1 k €	+1.4%	250,4 k €	+4.1%	240,5 k €	-6.8%	258,2 k €	+11.0%	232,6 k €	+2.8%	226,2 k €	+16.5%	194,1 k €	+5.5%	184 k €	-11.7%	208,3 k €	+3.2%	201,9 k €	+4.9%	192,4 k €
EBITDA	104,1 k €	+746%	12,3 k €	-77.8%	55,5 k €	-22.6%	71,7 k €	-4.5%	75 k €	-26.4%	102 k €	+57.2%	64,9 k €	+73.4%	37,4 k €	-39.8%	62,1 k €	-46.6%	116,4 k €	-1.8%	118,5 k €	+3.5%	114,5 k €	-15.4%	135,3 k €	+1.1%	133,8 k €	-0.3%	134,2 k €	+29.3%	103,8 k €	+6.5%	97,5 k €	-24.0%	128,2 k €	-6.8%	137,6 k €	-7.7%	149,1 k €
Operating result	55,4 k €	+253%	-36,1 k €	-18.3%	-30,5 k €	-144%	69,2 k €	-4.6%	72,5 k €	-27.1%	99,5 k €	+57.8%	63,1 k €	+75.8%	35,9 k €	-40.7%	60,4 k €	-46.1%	112,1 k €	-0.9%	113 k €	+30.0%	87 k €	+1.6%	85,6 k €	+2.4%	83,6 k €	-1.1%	84,5 k €	+51.8%	55,7 k €	+11.4%	50 k €	-45.8%	92,3 k €	-9.4%	101,9 k €	-10.4%	113,7 k €
Net result	26,5 k €	+140%	-65,9 k €	-39.1%	-47,4 k €	-188%	53,8 k €	-4.5%	56,3 k €	-30.7%	81,2 k €	+66.7%	48,7 k €	+82.2%	26,7 k €	-31.4%	39 k €	-50.0%	78 k €	+8.0%	72,2 k €	+15.5%	62,5 k €	+22.5%	51 k €	-25.6%	68,5 k €	+21.4%	56,4 k €	+61.9%	34,8 k €	+36.7%	25,5 k €	-55.5%	57,3 k €	-6.7%	61,4 k €	-8.8%	67,3 k €
Balance sheet
Equity	115,5 k €	-46.0%	214 k €	-43.7%	379,9 k €	-11.1%	427,3 k €	+14.4%	373,5 k €	+17.8%	317,2 k €	-30.4%	456 k €	-29.9%	650,3 k €	+4.3%	623,5 k €	+6.7%	584,6 k €	+15.4%	506,6 k €	+16.6%	434,4 k €	+237%	129 k €	-62.9%	348 k €	+24.5%	279,5 k €	+25.3%	223 k €	+18.5%	188,2 k €	+15.7%	162,7 k €	+4.7%	155,4 k €	-27.4%	214 k €
Total assets	1,5 M €	-8.6%	1,6 M €	+3.8%	1,6 M €	+227%	479,2 k €	+5.4%	454,9 k €	-23.9%	597,5 k €	+10.9%	538,8 k €	-25.9%	726,9 k €	+3.7%	700,6 k €	+1.0%	693,9 k €	+14.6%	605,4 k €	+12.7%	537,2 k €	-2.0%	548,1 k €	+15.5%	474,7 k €	+7.6%	441,3 k €	-1.8%	449,3 k €	+2.0%	440,5 k €	-16.4%	527 k €	-15.2%	621,5 k €	-2.4%	636,8 k €
Cash	56 k €	+148%	22,6 k €	-56.3%	51,7 k €	-83.7%	317,7 k €	+26.8%	250,4 k €	-31.1%	363,3 k €	+17.0%	310,5 k €	-41.3%	529,1 k €	-0.1%	529,8 k €	+6.0%	499,6 k €	+19.0%	420 k €	+17.2%	358,3 k €	+8.0%	331,9 k €	+259%	92,5 k €	-33.7%	139,4 k €	+22.6%	113,8 k €	+193%	38,8 k €	-66.6%	116 k €	+94.9%	59,5 k €	-69.5%	194,9 k €
Debts	1,4 M €	-3.0%	1,4 M €	+19.0%	1,2 M €	+2187%	51,9 k €	-36.2%	81,3 k €	-71.0%	280,3 k €	+238%	82,8 k €	+8.1%	76,6 k €	-0.6%	77,1 k €	-29.5%	109,3 k €	+11.3%	98,2 k €	-4.4%	102,7 k €	-75.5%	418,7 k €	+231%	126,6 k €	-19.0%	156,4 k €	-30.9%	226,2 k €	-10.3%	252,3 k €	-30.7%	364,3 k €	-21.8%	466,1 k €	+10.2%	422,8 k €
Other
Workforce	3,0 ETP	-6.3%	3,2 ETP	+88.2%	1,7 ETP	-26.1%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	+9.5%	2,1 ETP	0.0%	2,1 ETP	0.0%	2,1 ETP	0.0%	2,1 ETP	0.0%	2,1 ETP	0.0%	2,1 ETP	+90.9%	1,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 7 ended

Active mandates

AGANJU HOLDING

Managing director · 0694.526.532

Represented by HAMIAFO NGATCHI HERVE

Active

Ended mandates

AGANJU HOLDING

Director · since 01 février 2023 · 0694.526.532

Represented by Hervé HAMIAFO

Ended

AGANJU HOLDING

Director · since 01 janvier 2023 · 0694.526.532

Represented by Hervé Hamiafo Ngatchi

Ended

Isabelle ROUFOSSE

Director · since 01 janvier 2023 · until 31 janvier 2023

Ended

Isabelle Roufosse

Director · until 31 décembre 2022

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	28/08/2025	22/01/2025	31/08/2023	07/07/2022	20/07/2021
General meeting	08/06/2026	10/06/2025	10/06/2024	12/06/2023	13/06/2022	14/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	08/06/2026	31/08/2026	French	PDF
Abridged model	31/12/2024	10/06/2025	28/08/2025	French	PDF
Abridged model	31/12/2023	10/06/2024	22/01/2025	French	PDF
Abridged model	31/12/2022	12/06/2023	31/08/2023	French	PDF
Abridged model	31/12/2021	13/06/2022	07/07/2022	French	PDF
Abridged model	31/12/2020	14/06/2021	20/07/2021	French	PDF
Abridged model	31/12/2019	08/06/2020	16/10/2020	French	PDF
Abridged model	31/12/2018	10/06/2019	30/08/2019	French	PDF
Abridged model	31/12/2017	11/06/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	12/06/2017	19/07/2017	French	PDF
Abridged model	31/12/2015	13/06/2016	26/08/2016	French	PDF
Abridged model	31/12/2014	08/06/2015	27/08/2015	French	PDF
Abridged model	31/12/2013	10/06/2014	18/06/2014	French	PDF
Abridged model	31/12/2012	10/06/2013	04/07/2013	French	PDF
Abridged model	31/12/2011	11/06/2012	28/06/2012	French	PDF
Abridged model	31/12/2010	13/06/2011	11/07/2011	French	PDF
Abridged model	31/12/2009	14/06/2010	30/08/2010	French	PDF
Abridged model	31/12/2008	14/06/2009	24/06/2009	French	PDF
Abridged model	31/12/2007	14/06/2008	04/08/2008	French	PDF
Abridged model	31/12/2006	14/06/2007	03/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 7 ended

Active mandates

AGANJU HOLDING

Managing director · 0694.526.532

Represented by HAMIAFO NGATCHI HERVE

Active

Ended mandates

AGANJU HOLDING

Director · since 01 février 2023 · 0694.526.532

Represented by Hervé HAMIAFO

Ended

AGANJU HOLDING

Director · since 01 janvier 2023 · 0694.526.532

Represented by Hervé Hamiafo Ngatchi

Ended

Isabelle ROUFOSSE

Director · since 01 janvier 2023 · until 31 janvier 2023

Ended

Isabelle Roufosse

Director · until 31 décembre 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates31/01/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
PDF
Mandates24/01/2023
DEMISSIONS, NOMINATIONS
PDF
Capital / shares26/11/2018
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares12/03/2014
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Other07/03/2003
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202526,5 k €↑
2025
Name changeD5 PHARMA
2024
Annual accounts 2024-65,9 k €↓
2023
Annual accounts 2023-47,4 k €↓
2022
Annual accounts 202253,8 k €↓
2021
Annual accounts 202156,3 k €↓
2021
Name changePHARMACIE ROUFOSSE
2020
Annual accounts 202081,2 k €↑
2019
Annual accounts 201948,7 k €↑
2018
Annual accounts 201826,7 k €↓
2017
Annual accounts 201739 k €↓
2016
Annual accounts 201678 k €↑
2015
Annual accounts 201572,2 k €↑
2014
Annual accounts 201462,5 k €↑
2013
Annual accounts 201351 k €↓
2012
Annual accounts 201268,5 k €↑
2011
Annual accounts 201156,4 k €↑
2010
Annual accounts 201034,8 k €↑
2009
Annual accounts 200925,5 k €↓
2008
Annual accounts 200857,3 k €↓
2007
Annual accounts 200761,4 k €↓
2006
Annual accounts 200667,3 k €
27/02/2003
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

D5-PHARMA

Overview

What does D5-PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline